ginsenoside rh2 has been researched along with Acute Lung Injury in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, YS; Deng, JS; Hsieh, YH; Huang, GJ | 1 |
1 other study(ies) available for ginsenoside rh2 and Acute Lung Injury
| Article | Year |
|---|---|
Ginsenoside Rh2 Ameliorates Lipopolysaccharide-Induced Acute Lung Injury by Regulating the TLR4/PI3K/Akt/mTOR, Raf-1/MEK/ERK, and Keap1/Nrf2/HO-1 Signaling Pathways in Mice.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Antioxidants; Cytokines; Disease Models, Animal; Endotoxins; Extracellular Signal-Regulated MAP Kinases; Ginsenosides; Heme Oxygenase-1; Inflammation Mediators; Kelch-Like ECH-Associated Protein 1; Lung; Male; MAP Kinase Kinase Kinases; Membrane Proteins; Mice, Inbred ICR; NF-E2-Related Factor 2; Oxidative Stress; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-raf; Signal Transduction; Toll-Like Receptor 4; TOR Serine-Threonine Kinases | 2018 |